+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Allergic Conjunctivitis Drug"

Allergic Conjunctivitis - Pipeline Insight, 2024 - Product Thumbnail Image

Allergic Conjunctivitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Allergic Conjunctivitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Allergic Conjunctivitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Conjunctivitis Therapeutics Market 2021-2025 - Product Thumbnail Image

Conjunctivitis Therapeutics Market 2021-2025

  • Report
  • July 2021
  • 120 Pages
  • Global
From
From
From
From
From
  • 20 Results (Page 1 of 1)
Loading Indicator

Allergic conjunctivitis is a type of eye allergy that is caused by an allergic reaction to airborne allergens such as pollen, dust mites, and pet dander. Symptoms of allergic conjunctivitis include redness, itching, and tearing of the eyes. Treatment for allergic conjunctivitis typically involves the use of antihistamines, decongestants, and mast cell stabilizers. These medications can be administered orally, topically, or through eye drops. The allergic conjunctivitis drug market is a subset of the larger allergy drug market. This market is composed of a variety of medications that are used to treat allergic conjunctivitis. These medications are typically prescribed by an allergist or ophthalmologist and are available in both over-the-counter and prescription forms. Some companies in the allergic conjunctivitis drug market include Allergan, Bausch & Lomb, Novartis, Pfizer, and Sanofi. Show Less Read more